When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. A Revolutionary New Alzheimer’s Drug Was Just Approved by the ...

   www.aol.com/revolutionary-alzheimer-drug-just...

   The trial, which included 1,795 adults between the ages of 50 and 90 who had mild cognitive impairment due to early Alzheimer’s disease or mild Alzheimer’s disease-related dementia, grouped ...

3. Alzheimer's: Are newly approved drugs making a real-life ...

   www.aol.com/alzheimers-newly-approved-drugs...

   The FDA granted accelerated approval to aducanumab for the treatment of Alzheimer’s disease in 2021 based on its ability to clear amyloid plaques. While aducanumab was successful in clearing ...

4. Anti-amyloid drugs - Wikipedia

   en.wikipedia.org/wiki/Anti-amyloid_drugs

   Aducanumab, sold under the brand name Aduhelm, is a monoclonal antibody designed to treat Alzheimer's disease. It is a monoclonal antibody that targets aggregated forms (plaque) of amyloid beta (Aβ) found in the brains of people with Alzheimer's disease to reduce its buildup. [10] It was developed by Biogen and Eisai. [11] Aducanumab is given via intravenous infusion. [5] Aducanumab was ...

5. Certain Alzheimer’s disease medications may slow cognitive ...

   www.aol.com/certain-alzheimer-disease...

   People with dementia with Lewy bodies share many of the same symptoms of Alzheimer’s disease and Parkinson’s disease, including cognitive issues such as memory loss, problem-solving, and ...

6. Solanezumab - Wikipedia

   en.wikipedia.org/wiki/Solanezumab

   Solanezumab was safely used in combination with approved Alzheimer's disease treatment, such as acetylcholinesterase inhibitors or memantine, in the clinical trials. [1] [7] [8] Aside from Alzheimer's disease, there are other amyloid beta related diseases, in which solanezumab could be used, e.g., Down syndrome or cerebral amyloid angiopathy. [9]

7. Galantamine - Wikipedia

   en.wikipedia.org/wiki/Galantamine

   Galantamine, sold under the brand name Razadyne among others, is indicated for the treatment of mild to moderate vascular dementia and Alzheimer's disease. [6] [7] The first person to extract galantamine and theorize its usefulness in medicine, was the Bulgarian chemist Dimitar Paskov in 1959.